Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Plaque Rupture and Thrombosis
Davide Capodanno/LinkedIn
Jan 16, 2026, 05:00

Plaque Rupture and Thrombosis

Davide Capodanno, Full Professor of Cardiology at the University of Catania, shared on X:

“Plaque rupture with thrombosis drives ACS, and thin-cap fibroatheroma is the archetypal high-risk plaque. There are consistent features of vulnerability across imaging modalities (large plaque burden, small MLA, TCFA, high LCBI, positive remodelling, etc.), with risk increasing when multiple features coexist. Yet absolute event rates remain low, consistent with pathology data showing most plaque ruptures are clinically silent.

So should we prophylactically stent high-risk plaques? According to this Viewpoint, completed trials (PROSPECT ABSORB, PREVENT) suggest no durable reduction in death or MI versus optimal medical therapy—benefits are limited to fewer revascularisations, at the cost of many unnecessary PCIs. With modern medical therapy, a wait-and-see strategy appears safe, avoiding most interventions without adverse consequences. For now, data favor surveillance and aggressive medical therapy over preventive PCI.

READ THE VIEWPOINT HERE.

thrombosis

Stay updated with Hemostasis Today.

bleeding disorders Davide Capodanno fibroatheroma Health Hematology Hemostasis Hemostasis Today Medicine plaque rupture thrombosis
NewsFeed